Hormonal Cytoreduction and Radiotherapy for Carcinoma of the Prostate
- 1 May 1992
- journal article
- Published by Wiley in British Journal of Urology
- Vol. 69 (5) , 521-524
- https://doi.org/10.1111/j.1464-410x.1992.tb15601.x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Hormonal cytoreduction in locally advanced carcinoma of the prostate treated with definitive radiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 1987
- The relationship of dose to infield failure for stages A, B and C prostate cancer. An analysis of 1516 patientsInternational Journal of Radiation Oncology*Biology*Physics, 1987
- Impact of surgical staging in evaluating the radiotherapeutic outcome in RTOG phase III study for stage A2 and B prostate carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 1987
- Radiotherapy of prostate carcinoma: Results of treatment and complicationsRadiotherapy and Oncology, 1987
- The treatment of metastatic prostatic cancer with the slow release LHRH analogue, “Zoladex”European Journal of Cancer and Clinical Oncology, 1987
- Optimizing the radiation treatment and outcome of prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1985
- Patterns of care studies: Dose-response observations for local control of adenocarcinoma of the prostateInternational Journal of Radiation Oncology*Biology*Physics, 1985
- Improved control of bulky prostate carcinoma with sequential estrogen and radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Keynote address: The scientific basis of the present and future practice of clinical radiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 1983
- Acute side effects and late complications after radiotherapy of localized carcinoma of the prostateCancer Treatment Reviews, 1983